About Lundbeck
Lundbeck is a company based in Copenhagen (Denmark) founded in 1915.. The company has 5,710 employees as of December 31, 2024. Lundbeck has completed 8 acquisitions, including Abide Therapeutics, Alder and Alder Biopharmaceuticals. Lundbeck operates in a competitive market with competitors including Jazz Pharmaceuticals, Neurocrine, PTC Therapeutics, Biohaven Pharmaceutical and Sana Biotechnology, among others.
- Headquarter Copenhagen, Denmark
- Employees 5710 as on 31 Dec, 2024
- Stage Public
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name H. Lundbeck A/S Class A
-
Annual Revenue
$3.07 B (USD)10.77as on Dec 31, 2024
-
Net Profit
$437.41 M (USD)37.25as on Dec 31, 2024
-
EBITDA
$859.5 M (USD)18.42as on Dec 31, 2024
-
Latest Funding Round
$338.46 K (USD), Grant
Mar 01, 2019
-
Investors
European Union
& 1 more
-
Employee Count
5710
as on Dec 31, 2024
-
Investments & Acquisitions
Abide Therapeutics
& 7 more
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
IPO & Listings of Lundbeck
Lundbeck is a publicly listed company on the OMXCOP with ticker symbol HLUN_A in Denmark, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
Unlock access to complete
Unlock access to complete
Leadership Team
121 people
Software Development Team
85 people
Sales and Marketing
47 people
Finance and Accounting
39 people
Human Resources and Administration
38 people
Product Management Team
35 people
Senior Team
34 people
Legal and Compliance
24 people
Unlock access to complete
Funding Insights of Lundbeck
- Total Funding Total Funding
- Total Rounds 8
- Last Round Grant — $338,463
-
First Round
First Round
(01 Jun 2011)
- Investors Count 2
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Mar, 2019 | Amount | Grant - Lundbeck | Valuation |
investors |
|
| Jan, 2017 | Amount | Grant - Lundbeck | Valuation |
investors |
|
| Dec, 2016 | Amount | Grant - Lundbeck | Valuation |
investors |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Lundbeck
Lundbeck has secured backing from 2 investors, including institutional and venture fund investors. Prominent investors backing the company include European Union and IFU. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Private equity investment firm
|
Founded Year | Domain | Location | |
|
Government entites focused on freedom, democracy, equality and the rule of law, promoting peace and stability
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Lundbeck
Lundbeck has strategically engaged in corporate development activities, having acquired 8 companies. Notable acquisitions include Abide Therapeutics, Alder and Alder Biopharmaceuticals. These strategic investments and acquisitions demonstrate the company's commitment to growth through portfolio expansion, market consolidation, technology integration, and strategic partnerships that enhance competitive positioning and drive long-term value creation.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Therapeutic solutions for rare neurological diseases are developed.
|
2020 | ||||
|
Parkinson's drugs targeting mGluR3 and mGluR4 receptors are developed.
|
2012 | ||||
|
Serine hydrolase inhibitors are developed for pain management.
|
2011 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
OVO is recognized as a smart digital payment application.
|
2017 | ||||
|
Bionic investment advisor platform
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 |
Financial Statements - Lundbeck
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Lundbeck Comparisons
Competitors of Lundbeck
Lundbeck operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Jazz Pharmaceuticals, Neurocrine, PTC Therapeutics, Biohaven Pharmaceutical and Sana Biotechnology, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Novel biopharmaceutical medicines are developed for unmet medical needs.
|
|
| domain | founded_year | HQ Location |
Developer of small molecule therapeutics for endocrine and CNS disorders
|
|
| domain | founded_year | HQ Location |
Small molecule drugs for rare diseases are developed.
|
|
| domain | founded_year | HQ Location |
Therapies for neurological and neuropsychiatric diseases are developed.
|
|
| domain | founded_year | HQ Location |
Genetically engineered cell therapies are developed for multiple disorders.
|
|
| domain | founded_year | HQ Location |
Therapies for psychosis and cognitive impairment are developed.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Lundbeck
Frequently Asked Questions about Lundbeck
When was Lundbeck founded?
Lundbeck was founded in 1915 and raised its 1st funding round 96 years after it was founded.
Where is Lundbeck located?
Lundbeck is headquartered in Copenhagen, Denmark.
How many employees does Lundbeck have?
As of Dec 31, 2024, the latest employee count at Lundbeck is 5,710.
What is the annual revenue of Lundbeck?
Annual revenue of Lundbeck is $3.07B as on Dec 31, 2024.
What does Lundbeck do?
The company was founded in 1915 in Copenhagen, Denmark, and operates within the pharmaceutical sector. Emphasis is placed on developing treatments for central nervous system disorders. The lead product, Eptinezumab, is a monoclonal antibody used for migraine and cluster headache management. A research pipeline is pursued for depression, schizophrenia, Alzheimers disease, Parkinsons disease, and insomnia, with operations centered in Europe and global outreach.
Who are the top competitors of Lundbeck?
Lundbeck's top competitors include Jazz Pharmaceuticals, PTC Therapeutics and Neurocrine.
Is Lundbeck publicly traded?
Yes, Lundbeck is publicly traded on OMXCOP under the ticker symbol HLUN_A.
How many acquisitions has Lundbeck made?
Lundbeck has made 8 acquisitions, including Abide Therapeutics, Alder, and Alder Biopharmaceuticals.
Who are Lundbeck's investors?
Lundbeck has 2 investors. Key investors include European Union, and IFU.
What is Lundbeck's ticker symbol?
The ticker symbol of Lundbeck is HLUN_A on OMXCOP.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.